Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion description "[These results not only highlight the potential of a synergistic drug combination of allosteric PARP inhibitors with DNA-damaging agents in genomically unstable cancer cells (regardless of homologous recombination status), but also signify important applications of selective PARP-1 inhibition.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion evidence source_evidence_literature NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion SIO_000772 24189460 NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion wasDerivedFrom befree-20150227 NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_assertion wasGeneratedBy ECO_0000203 NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.
- befree-20150227 importedOn "2015-02-27" NP320920.RAtJm0kXWn6oYWncp5a03VhSVI6gL3MLiwkTRKrkocvWg130_provenance.